Dacomitinib usage and correct dosage guidelines
Dacomitinib is a targeted anti-cancer drug mainly used to treat non-small cell lung cancer (NSCLC). As an irreversible tyrosine kinase inhibitor (TKI), dacomitinib inhibits EGFR (epidermal growth factor receptor) mutations, reducing the proliferation and metastasis of cancer cells, thereby achieving anti-tumor effects. In order to ensure the best efficacy, patients need to follow the correct medication methods and precautions when taking dacomitinib.
1.Medicine administration method
Dacomitinib is usually given as an oral tablet. The recommended dose for adults is 45 mg once a day, before or after a meal, but it is best to take it at a fixed time every day to ensure stable drug concentration. Patients should swallow the tablets whole and avoid crushing, chewing, or dissolving the tablets, as this may affect absorption or increase side effects.
If a dose is missed, patients should try to take it on the same day, but should not take two more doses as the next dose approaches. If in doubt, it is best to consult a doctor or pharmacist to ensure the correct supplement method.
2.Dose adjustment
During the use of dacomitinib, side effect management is a very important part of the treatment. Common side effects include rash, diarrhea, stomatitis, loss of appetite, etc. If discomfort occurs, patients should promptly report to their doctor, and dosage adjustments may be required based on the severity of side effects. For mild side effects, you may choose to continue using the original dose, while for severe side effects, such as severe gastrointestinal discomfort or excessive rash, you may need to temporarily discontinue the medication or reduce the dose.
For example, if a patient develops a severe rash or gastrointestinal symptoms, the doctor may recommend reducing the dose or temporarily discontinuing the drug and then resuming it when the side effects subside. When restoring the dose, usually start with **50%** of the original dose and gradually return to the full dose.

3. Things to note about diet and living habits
Although dacomitinib can be taken with food, there are some dietary habits that may affect the absorption of the drug. For example, avoid taking it with foods high in fat, as fat-rich foods may delay the absorption of the drug, thereby affecting its effectiveness. Patients should follow their doctor's advice and maintain good eating habits to ensure the best effect of the medication.
In addition, patients should avoid co-administration with certain drugs, especially potent onesCYP3A4Inhibitors or inducers, such as certain antibiotics, antifungals, and antiepileptic drugs. These drugs may increase dacomitinib plasma concentrations or decrease its efficacy. Before starting dacomitinib, patients should inform their doctor in detail about other drugs they are taking.
4.Side effects management and regular monitoring
Side effects of dacomitinib include rash, diarrhea, stomatitis, loss of appetite, etc. These side effects are usually more common in the early stages of treatment, but many side effects will be relieved as treatment continues. Patients should undergo regular blood tests during use, and monitor liver and kidney function and white blood cell count in order to detect potential drug toxicity in a timely manner and ensure the safety of the drug.
Especially for severe diarrhea, timely measures should be taken under the guidance of a doctor to prevent dehydration and electrolyte imbalance. Your doctor may recommend an anti-diarrhoeal drug, such as loperamide, and adjust the dacomitinib dose based on your patient's specific condition.
Dacomitinib is an effective targeted therapy, especially important for patients with non-small cell lung cancer. In order to ensure the best efficacy, patients need to strictly follow the doctor's instructions, take medications on time, pay attention to side effects and conduct regular monitoring. Adjustment of dosage and proper management of side effects are critical to maintaining drug efficacy and improving patient quality of life. At the same time, patients should also avoid interactions with certain drugs and pay attention to adjustments in dietary habits to ensure the maximum effectiveness of the drugs.
Reference materials:https://www.pfizer.com/products/product-detail/vizimpro
[ 免责声明 ] 本页面内容来自公开渠道(如FDA官网、Drugs官网、原研药厂官网等),仅供持有医疗专业资质的人员用于医学药学研究参考,不构成任何治疗建议或药品推荐。所涉药品可能未在中国大陆获批上市,不适用于中国境内销售和使用。如需治疗,请咨询正规医疗机构。本站不提供药品销售或代购服务。
.jpeg)